COVID‐19 and DSM changes tied to rising ADHD diagnoses rates
Mental Health Weekly · 27.04.2026 · 36 (17) · 6-7
DOI: 10.1002/mhw.34846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mental Health Weekly, online erschienen am 24.04.2026. Verfasst von Valerie A. Canady.
Abstract (Originalsprache)
Attention‐deficit/hyperactivity disorder (ADHD) is one of the most frequently diagnosed neurodevelopmental conditions among children and adolescents, yet the drivers behind recent increases in diagnosis rates are not fully understood, according to authors of a research letter published last week in JAMA Network Open .
Zitieren
APA
Canady, V. A. (2026). COVID‐19 and DSM changes tied to rising ADHD diagnoses rates. Mental Health Weekly, 36(17), 6-7. https://doi.org/10.1002/mhw.34846
Vancouver
Canady VA. COVID‐19 and DSM changes tied to rising ADHD diagnoses rates. Mental Health Weekly. 2026;36(17):6-7. doi:10.1002/mhw.34846
BibTeX
@article{Canady2026,
author = {Canady, Valerie A.},
title = {COVID‐19 and DSM changes tied to rising ADHD diagnoses rates},
journal = {Mental Health Weekly},
year = {2026},
volume = {36},
number = {17},
pages = {6--7},
doi = {10.1002/mhw.34846}
}
EUVIMED